JOSHUA BLANCHER: Open Payments
NPI 1750817557 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,565 in 104 payments from 22 companies in 2025. Trend: 2023 $2,386 · 2024 $3,536 · 2025 $2,565
Food & beverage: $2,466Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $644 |
| GENZYME CORPORATION | 19 | $408 |
| GlaxoSmithKline, LLC. | 21 | $273 |
| Regeneron Healthcare Solutions, Inc. | 7 | $186 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $181 |
| Novartis Pharmaceuticals Corporation | 7 | $143 |
| CSL Behring | 6 | $127 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| Amgen Inc. | 2 | $53 |
Products named: DUPIXENT, AIRSUPRA, TEZSPIRE, NEFFY, TRELEGY ELLIPTA, FASENRA, Hizentra, NUCALA.
Industry payments across KY — which companies pay providers there.
